Galmed Pharmaceuticals Ltd. GLMD

Set alert

Price alert · GLMD

All alert types
4.63 USD +0.80 +21.05%

At close · Sep 9

0.57 -4.06 -87.61%

After hours · Sep 9, 4:00 PM ET

Bid
0.56 × 2
Ask
0.57 × 2
3.82 Day range 4.63
0.4111 52-week range 5.45
YTD
+516.51%
1 year
+158.66%
Open
3.91
Prev close
3.83
Mkt cap
4.78M
Vol
301.15K
Avg vol
52.89K
EPS
-15.18
P/E
0.00
Div yield
0.00%
More statistics
Low
3.82
High
4.63
Forward P/E
-2.94
Beta
0.80
Short ratio
0.27
Inst. own
0.48%
Dividend
0.00
Ex-div date
50-d avg
3.25
200-d avg
4.07
1y target
0.00

MAX chart

Chart tools
Interval

Events in this range
  • Aug 19, 2026Split: 1 for 8
Signals (80)
NameDateAgo
SMA: BullishSep 9, 20261 month ago
SMA: BullishSep 9, 20261 month ago
MACD: Buy SignalSep 9, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 8, 20261 month ago
SMA: BearishSep 3, 20261 month ago
SMA: BearishSep 3, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 2, 20262 months ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 26, 20262 months ago
SMA: BearishAug 25, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
SMA: BearishAug 20, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BullishAug 18, 20262 months ago
MACD: Buy SignalAug 18, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BearishAug 17, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago
MACD: Sell SignalAug 13, 20262 months ago
SMA: BearishAug 13, 20262 months ago
MACD: Buy SignalAug 13, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishAug 5, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishAug 4, 20262 months ago
SMA: BullishAug 4, 20262 months ago
SMA: BearishAug 4, 20262 months ago
MACD: Sell SignalAug 3, 20263 months ago
SMA: BearishAug 3, 20263 months ago
SMA: BullishJul 29, 20263 months ago
MACD: Buy SignalJul 29, 20263 months ago
SMA: BearishJul 29, 20263 months ago
MACD: Sell SignalJul 29, 20263 months ago
SMA: BullishJul 28, 20263 months ago
SMA: BearishJul 28, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 27, 20263 months ago
SMA: BullishJul 23, 20263 months ago
SMA: BullishJul 23, 20263 months ago
SMA: BearishJul 23, 20263 months ago
SMA: BullishJul 22, 20263 months ago
SMA: BearishJul 22, 20263 months ago
SMA: BullishJul 21, 20263 months ago
SMA: BearishJul 21, 20263 months ago
SMA: BullishJul 21, 20263 months ago

Financial health

Altman Z-Score

-17.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -28.2×FY 2017: -114×FY 2018: -151×FY 2019: -79.0×FY 2020: -28.8×FY 2021: -16.8×FY 2022: -8.1×FY 2023: -0.2×FY 2024: -0.4×FY 2025: -0.3×
FY 2016 5y median -0.4× FY 2025
P/S 0.0×
FY 2016: 1025×FY 2017: 1296×FY 2018: 729×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 43.2×FY 2017: 89.0×FY 2018: 16.9×FY 2019: 21.0×FY 2020: 18.0×FY 2021: 17.6×FY 2022: 11.2×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/FCF -0.5×
FY 2016: -39.4×FY 2017: -116×FY 2018: -163×FY 2019: -97.9×FY 2020: -30.1×FY 2021: -16.3×FY 2022: -8.1×FY 2023: -0.2×FY 2024: -0.5×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
EV/EBITDA 0.1×
FY 2016: -28.5×FY 2017: -115×FY 2018: -142×FY 2019: -64.8×FY 2020: -26.1×FY 2021: -16.5×FY 2022: -8.5×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2016: 1019×FY 2017: 1284×FY 2018: 717×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -195.3%
FY 2016: -2.5%FY 2017: -0.9%FY 2018: -0.6%FY 2019: -1.0%FY 2020: -3.3%FY 2021: -6.1%FY 2022: -12.3%FY 2023: -505.4%FY 2024: -198.0%FY 2025: -195.3%
FY 2016 5y median -195.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -3615.0%FY 2017: -1139.5%FY 2018: -525.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -3630.2%FY 2017: -1133.5%FY 2018: -483.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -65.3%
FY 2016: -153.1%FY 2017: -77.9%FY 2018: -11.2%FY 2019: -29.3%FY 2020: -65.2%FY 2021: -106.5%FY 2022: -133.1%FY 2023: -49.8%FY 2024: -46.0%FY 2025: -65.3%
FY 2016 5y median -65.3% FY 2025
ROIC -53.9%
FY 2016: -142.2%FY 2017: -78.3%FY 2018: -12.2%FY 2019: -31.9%FY 2020: -68.1%FY 2021: -107.0%FY 2022: -129.4%FY 2023: -53.8%FY 2024: -38.5%FY 2025: -53.9%
FY 2016 5y median -53.9% FY 2025
ROA -55.3%
FY 2016: -103.1%FY 2017: -62.6%FY 2018: -10.9%FY 2019: -26.5%FY 2020: -54.9%FY 2021: -88.7%FY 2022: -107.9%FY 2023: -41.6%FY 2024: -40.6%FY 2025: -55.3%
FY 2016 5y median -55.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 132.3%FY 2018: 87.8%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -35.6%
FY 2016: -55.2%FY 2017: 26.8%FY 2018: 13.3%FY 2019: -108.8%FY 2020: -35.0%FY 2021: -8.8%FY 2022: 46.3%FY 2023: 57.6%FY 2024: 16.2%FY 2025: -35.6%
FY 2016 FY 2025
EPS (diluted) 70.4%
FY 2016: -55.8%FY 2017: 33.9%FY 2018: 44.8%FY 2019: -61.6%FY 2020: -47.8%FY 2021: -0.1%FY 2022: 43.1%FY 2023: -170.3%FY 2024: 73.0%FY 2025: 70.4%
FY 2016 FY 2025
Free Cash Flow -7.4%
FY 2016: -40.7%FY 2017: 0.5%FY 2018: 24.6%FY 2019: -64.0%FY 2020: -76.1%FY 2021: -25.0%FY 2022: 43.8%FY 2023: 66.8%FY 2024: 4.2%FY 2025: -7.4%
FY 2016 FY 2025

Financial Health

Current Ratio 6.5×
FY 2016: 3.4×FY 2017: 5.0×FY 2018: 33.4×FY 2019: 11.0×FY 2020: 6.5×FY 2021: 6.1×FY 2022: 4.8×FY 2023: 4.8×FY 2024: 7.4×FY 2025: 6.5×
FY 2016 5y median 6.1× FY 2025
Quick Ratio 6.5×
FY 2016: 3.5×FY 2017: 5.0×FY 2018: 33.4×FY 2019: 11.0×FY 2020: 6.5×FY 2021: 6.1×FY 2022: 4.8×FY 2023: 4.8×FY 2024: 7.4×FY 2025: 6.5×
FY 2016 5y median 6.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.2×FY 2017: 1.1×FY 2018: 2.3×FY 2019: 0.7×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.4×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -252×FY 2017: -252×FY 2018: -255×FY 2019: -678×FY 2020: -975×FY 2021: -765×FY 2022: -82.1×FY 2023: -681×FY 2024: -419×FY 2025: 0.0×
FY 2016 5y median -419× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31